The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Remimazolam-Global Market Insights and Sales Trends 2024
Synopsis
Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.
The global Remimazolam market size is expected to reach US$ 610.7 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Remimazolam in various end use industries. The expanding demands from the Surgical Anesthesia, ICU Sedation and Other,, are propelling Remimazolam market. 2.5mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 20mg segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Remimazolam, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Remimazolam market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Remimazolam market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Remimazolam sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Remimazolam covered in this report include Paion, Yichang Renfu Pharmaceutical, Jiangsu Hengrui Medicine, Cosmo Pharmaceuticals, Mundipharma, Pharmascience and Hana Pharm, etc.
The global Remimazolam market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Paion
Yichang Renfu Pharmaceutical
Jiangsu Hengrui Medicine
Cosmo Pharmaceuticals
Mundipharma
Pharmascience
Hana Pharm
Global Remimazolam market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Remimazolam market, Segment by Type:
2.5mg
20mg
Global Remimazolam market, by Application
Surgical Anesthesia
ICU Sedation
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Remimazolam manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Remimazolam in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.
The global Remimazolam market size is expected to reach US$ 610.7 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Remimazolam in various end use industries. The expanding demands from the Surgical Anesthesia, ICU Sedation and Other,, are propelling Remimazolam market. 2.5mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 20mg segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Remimazolam, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Remimazolam market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Remimazolam market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Remimazolam sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Remimazolam covered in this report include Paion, Yichang Renfu Pharmaceutical, Jiangsu Hengrui Medicine, Cosmo Pharmaceuticals, Mundipharma, Pharmascience and Hana Pharm, etc.
The global Remimazolam market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Paion
Yichang Renfu Pharmaceutical
Jiangsu Hengrui Medicine
Cosmo Pharmaceuticals
Mundipharma
Pharmascience
Hana Pharm
Global Remimazolam market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Remimazolam market, Segment by Type:
2.5mg
20mg
Global Remimazolam market, by Application
Surgical Anesthesia
ICU Sedation
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Remimazolam manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Remimazolam in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Remimazolam Market Overview
1.1 Remimazolam Product Overview
1.2 Remimazolam Market Segment by Type
1.2.1 2.5mg
1.2.2 20mg
1.3 Global Remimazolam Market Size by Type
1.3.1 Global Remimazolam Market Size Overview by Type (2018-2029)
1.3.2 Global Remimazolam Historic Market Size Review by Type (2018-2023)
1.3.3 Global Remimazolam Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Remimazolam Sales Breakdown by Type (2018-2023)
1.4.2 Europe Remimazolam Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Remimazolam Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Remimazolam Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Remimazolam Sales Breakdown by Type (2018-2023)
2 Global Remimazolam Market Competition by Company
2.1 Global Top Players by Remimazolam Sales (2018-2023)
2.2 Global Top Players by Remimazolam Revenue (2018-2023)
2.3 Global Top Players by Remimazolam Price (2018-2023)
2.4 Global Top Manufacturers Remimazolam Manufacturing Base Distribution, Sales Area, Product Type
2.5 Remimazolam Market Competitive Situation and Trends
2.5.1 Remimazolam Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Remimazolam Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Remimazolam as of 2022)
2.7 Date of Key Manufacturers Enter into Remimazolam Market
2.8 Key Manufacturers Remimazolam Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Remimazolam Status and Outlook by Region
3.1 Global Remimazolam Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Remimazolam Historic Market Size by Region
3.2.1 Global Remimazolam Sales in Volume by Region (2018-2023)
3.2.2 Global Remimazolam Sales in Value by Region (2018-2023)
3.2.3 Global Remimazolam Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Remimazolam Forecasted Market Size by Region
3.3.1 Global Remimazolam Sales in Volume by Region (2024-2029)
3.3.2 Global Remimazolam Sales in Value by Region (2024-2029)
3.3.3 Global Remimazolam Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Remimazolam by Application
4.1 Remimazolam Market Segment by Application
4.1.1 Surgical Anesthesia
4.1.2 ICU Sedation
4.1.3 Other
4.2 Global Remimazolam Market Size by Application
4.2.1 Global Remimazolam Market Size Overview by Application (2018-2029)
4.2.2 Global Remimazolam Historic Market Size Review by Application (2018-2023)
4.2.3 Global Remimazolam Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Remimazolam Sales Breakdown by Application (2018-2023)
4.3.2 Europe Remimazolam Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Remimazolam Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Remimazolam Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Remimazolam Sales Breakdown by Application (2018-2023)
5 North America Remimazolam by Country
5.1 North America Remimazolam Historic Market Size by Country
5.1.1 North America Remimazolam Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Remimazolam Sales in Volume by Country (2018-2023)
5.1.3 North America Remimazolam Sales in Value by Country (2018-2023)
5.2 North America Remimazolam Forecasted Market Size by Country
5.2.1 North America Remimazolam Sales in Volume by Country (2024-2029)
5.2.2 North America Remimazolam Sales in Value by Country (2024-2029)
6 Europe Remimazolam by Country
6.1 Europe Remimazolam Historic Market Size by Country
6.1.1 Europe Remimazolam Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Remimazolam Sales in Volume by Country (2018-2023)
6.1.3 Europe Remimazolam Sales in Value by Country (2018-2023)
6.2 Europe Remimazolam Forecasted Market Size by Country
6.2.1 Europe Remimazolam Sales in Volume by Country (2024-2029)
6.2.2 Europe Remimazolam Sales in Value by Country (2024-2029)
7 Asia-Pacific Remimazolam by Region
7.1 Asia-Pacific Remimazolam Historic Market Size by Region
7.1.1 Asia-Pacific Remimazolam Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Remimazolam Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Remimazolam Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Remimazolam Forecasted Market Size by Region
7.2.1 Asia-Pacific Remimazolam Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Remimazolam Sales in Value by Region (2024-2029)
8 Latin America Remimazolam by Country
8.1 Latin America Remimazolam Historic Market Size by Country
8.1.1 Latin America Remimazolam Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Remimazolam Sales in Volume by Country (2018-2023)
8.1.3 Latin America Remimazolam Sales in Value by Country (2018-2023)
8.2 Latin America Remimazolam Forecasted Market Size by Country
8.2.1 Latin America Remimazolam Sales in Volume by Country (2024-2029)
8.2.2 Latin America Remimazolam Sales in Value by Country (2024-2029)
9 Middle East and Africa Remimazolam by Country
9.1 Middle East and Africa Remimazolam Historic Market Size by Country
9.1.1 Middle East and Africa Remimazolam Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Remimazolam Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Remimazolam Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Remimazolam Forecasted Market Size by Country
9.2.1 Middle East and Africa Remimazolam Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Remimazolam Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Paion
10.1.1 Paion Company Information
10.1.2 Paion Introduction and Business Overview
10.1.3 Paion Remimazolam Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Paion Remimazolam Products Offered
10.1.5 Paion Recent Development
10.2 Yichang Renfu Pharmaceutical
10.2.1 Yichang Renfu Pharmaceutical Company Information
10.2.2 Yichang Renfu Pharmaceutical Introduction and Business Overview
10.2.3 Yichang Renfu Pharmaceutical Remimazolam Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Yichang Renfu Pharmaceutical Remimazolam Products Offered
10.2.5 Yichang Renfu Pharmaceutical Recent Development
10.3 Jiangsu Hengrui Medicine
10.3.1 Jiangsu Hengrui Medicine Company Information
10.3.2 Jiangsu Hengrui Medicine Introduction and Business Overview
10.3.3 Jiangsu Hengrui Medicine Remimazolam Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Jiangsu Hengrui Medicine Remimazolam Products Offered
10.3.5 Jiangsu Hengrui Medicine Recent Development
10.4 Cosmo Pharmaceuticals
10.4.1 Cosmo Pharmaceuticals Company Information
10.4.2 Cosmo Pharmaceuticals Introduction and Business Overview
10.4.3 Cosmo Pharmaceuticals Remimazolam Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cosmo Pharmaceuticals Remimazolam Products Offered
10.4.5 Cosmo Pharmaceuticals Recent Development
10.5 Mundipharma
10.5.1 Mundipharma Company Information
10.5.2 Mundipharma Introduction and Business Overview
10.5.3 Mundipharma Remimazolam Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mundipharma Remimazolam Products Offered
10.5.5 Mundipharma Recent Development
10.6 Pharmascience
10.6.1 Pharmascience Company Information
10.6.2 Pharmascience Introduction and Business Overview
10.6.3 Pharmascience Remimazolam Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pharmascience Remimazolam Products Offered
10.6.5 Pharmascience Recent Development
10.7 Hana Pharm
10.7.1 Hana Pharm Company Information
10.7.2 Hana Pharm Introduction and Business Overview
10.7.3 Hana Pharm Remimazolam Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hana Pharm Remimazolam Products Offered
10.7.5 Hana Pharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Remimazolam Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Remimazolam Industrial Chain Analysis
11.4 Remimazolam Market Dynamics
11.4.1 Remimazolam Industry Trends
11.4.2 Remimazolam Market Drivers
11.4.3 Remimazolam Market Challenges
11.4.4 Remimazolam Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Remimazolam Distributors
12.3 Remimazolam Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
